121 related articles for article (PubMed ID: 15556769)
1. A molecular docking study of estrogenically active compounds with 1,2-diarylethane and 1,2-diarylethene pharmacophores.
Kekenes-Huskey PM; Muegge I; von Rauch M; Gust R; Knapp EW
Bioorg Med Chem; 2004 Dec; 12(24):6527-37. PubMed ID: 15556769
[TBL] [Abstract][Full Text] [Related]
2. Prediction of ligand binding affinity and orientation of xenoestrogens to the estrogen receptor by molecular dynamics simulations and the linear interaction energy method.
van Lipzig MM; ter Laak AM; Jongejan A; Vermeulen NP; Wamelink M; Geerke D; Meerman JH
J Med Chem; 2004 Feb; 47(4):1018-30. PubMed ID: 14761204
[TBL] [Abstract][Full Text] [Related]
3. Molecular simulation of interaction between estrogen receptor and selective estrogen receptor modulators.
Guo ZR; Yi X; Xu ZB
Acta Pharmacol Sin; 2002 Mar; 23(3):208-12. PubMed ID: 11918843
[TBL] [Abstract][Full Text] [Related]
4. Simulation of the different biological activities of diethylstilbestrol (DES) on estrogen receptor alpha and estrogen-related receptor gamma.
Nam K; Marshall P; Wolf RM; Cornell W
Biopolymers; 2003 Jan; 68(1):130-8. PubMed ID: 12579585
[TBL] [Abstract][Full Text] [Related]
5. Structural aspects of agonism and antagonism in the oestrogen receptor.
Pike AC; Brzozowski AM; Walton J; Hubbard RE; Bonn T; Gustafsson JA; Carlquist M
Biochem Soc Trans; 2000; 28(4):396-400. PubMed ID: 10961927
[TBL] [Abstract][Full Text] [Related]
6. Discovery and structure-activity analysis of selective estrogen receptor modulators via similarity-based virtual screening.
Shen J; Jiang J; Kuang G; Tan C; Liu G; Huang J; Tang Y
Eur J Med Chem; 2012 Aug; 54():188-96. PubMed ID: 22647217
[TBL] [Abstract][Full Text] [Related]
7. Integrating medicinal chemistry, organic/combinatorial chemistry, and computational chemistry for the discovery of selective estrogen receptor modulators with Forecaster, a novel platform for drug discovery.
Therrien E; Englebienne P; Arrowsmith AG; Mendoza-Sanchez R; Corbeil CR; Weill N; Campagna-Slater V; Moitessier N
J Chem Inf Model; 2012 Jan; 52(1):210-24. PubMed ID: 22133077
[TBL] [Abstract][Full Text] [Related]
8. Combining protein modeling and 6D-QSAR. Simulating the binding of structurally diverse ligands to the estrogen receptor.
Vedani A; Dobler M; Lill MA
J Med Chem; 2005 Jun; 48(11):3700-3. PubMed ID: 15916421
[TBL] [Abstract][Full Text] [Related]
9. Selective estrogen receptor modulators with conformationally restricted side chains. Synthesis and structure-activity relationship of ERalpha-selective tetrahydroisoquinoline ligands.
Renaud J; Bischoff SF; Buhl T; Floersheim P; Fournier B; Geiser M; Halleux C; Kallen J; Keller H; Ramage P
J Med Chem; 2005 Jan; 48(2):364-79. PubMed ID: 15658851
[TBL] [Abstract][Full Text] [Related]
10. Novel estrogen receptor ligands based on an anthranylaldoxime structure: role of the phenol-type pseudocycle in the binding process.
Minutolo F; Antonello M; Bertini S; Ortore G; Placanica G; Rapposelli S; Sheng S; Carlson KE; Katzenellenbogen BS; Katzenellenbogen JA; Macchia M
J Med Chem; 2003 Sep; 46(19):4032-42. PubMed ID: 12954056
[TBL] [Abstract][Full Text] [Related]
11. Selective estrogen receptor modulators (SERMs): mechanisms of anticarcinogenesis and drug resistance.
Lewis JS; Jordan VC
Mutat Res; 2005 Dec; 591(1-2):247-63. PubMed ID: 16083919
[TBL] [Abstract][Full Text] [Related]
12. [Selective estrogen receptor modulators: mechanisms of action and their tissue selectivity].
Azuma K; Inoue S
Clin Calcium; 2004 Oct; 14(10):12-26. PubMed ID: 15577127
[TBL] [Abstract][Full Text] [Related]
13. Structure-based approach for the study of estrogen receptor binding affinity and subtype selectivity.
Salum LB; Polikarpov I; Andricopulo AD
J Chem Inf Model; 2008 Nov; 48(11):2243-53. PubMed ID: 18937440
[TBL] [Abstract][Full Text] [Related]
14. Three-dimensional models of non-steroidal ligands: a comparative molecular field analysis.
Menezes IR; Leitão A; Montanari CA
Steroids; 2006 Jun; 71(6):417-28. PubMed ID: 16481019
[TBL] [Abstract][Full Text] [Related]
15. QSAR of estrogen receptor modulators: exploring selectivity requirements for ER(alpha) versus ER(beta) binding of tetrahydroisoquinoline derivatives using E-state and physicochemical parameters.
Mukherjee S; Saha A; Roy K
Bioorg Med Chem Lett; 2005 Feb; 15(4):957-61. PubMed ID: 15686893
[TBL] [Abstract][Full Text] [Related]
16. Receptor binding characteristics of the endocrine disruptor bisphenol A for the human nuclear estrogen-related receptor gamma. Chief and corroborative hydrogen bonds of the bisphenol A phenol-hydroxyl group with Arg316 and Glu275 residues.
Liu X; Matsushima A; Okada H; Tokunaga T; Isozaki K; Shimohigashi Y
FEBS J; 2007 Dec; 274(24):6340-51. PubMed ID: 18005256
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and structure guided evaluation of estrogen agonist and antagonist activities of some new tetrazolyl indole derivatives.
Singh US; Shankar R; Yadav GP; Kharkwal G; Dwivedi A; Keshri G; Singh MM; Moulik PR; Hajela K
Eur J Med Chem; 2008 Oct; 43(10):2149-58. PubMed ID: 18155810
[TBL] [Abstract][Full Text] [Related]
18. Structural and chemical basis for enhanced affinity and potency for a large series of estrogen receptor ligands: 2D and 3D QSAR studies.
Salum Lde B; Polikarpov I; Andricopulo AD
J Mol Graph Model; 2007 Sep; 26(2):434-42. PubMed ID: 17349808
[TBL] [Abstract][Full Text] [Related]
19. Insights into ligand selectivity in estrogen receptor isoforms: molecular dynamics simulations and binding free energy calculations.
Zeng J; Li W; Zhao Y; Liu G; Tang Y; Jiang H
J Phys Chem B; 2008 Mar; 112(9):2719-26. PubMed ID: 18266357
[TBL] [Abstract][Full Text] [Related]
20. Molecular structural characteristics as determinants of estrogen receptor selectivity.
Agatonovic-Kustrin S; Turner JV; Glass BD
J Pharm Biomed Anal; 2008 Sep; 48(2):369-75. PubMed ID: 18511229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
